Chiquita Brooks-LaSure, CMS administrator (Evan Vucci/AP Images)
June 26, 2024 12:59 PM EDT
Pharma
FDA+

HHS re­veals 64 drugs up for Medicare in­fla­tion re­bates next quar­ter

Nicole DeFeudis

Editor

More drugs than ever will be sub­ject to Medicare in­fla­tion re­bates un­der the In­fla­tion Re­duc­tion Act next quar­ter.

On Wednes­day, the De­part­ment of Health and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Why the Supreme Court's over­rule of Chevron has ma­jor im­pli­ca­tions for the FDA

J&J de­tails Phase 3 suc­cess of au­toim­mune dis­ease drug, tout­ing broad­er range than ar­genx’s Vyv­gart

FDA re­jects Rock­et Phar­ma’s ul­tra-rare im­mune dis­ease gene ther­a­py over man­u­fac­tur­ing

Supreme Court nar­row­ly re­jects Pur­due bank­rupt­cy plan, says it gives Sack­lers too much pro­tec­tion

GSK’s man­u­fac­tur­ing sites in Sin­ga­pore will use 100% re­new­able en­er­gy by 2025 

Bio­phar­ma lead­ers chart­ing a path for the in­dus­try's LGBTQ+ com­mu­ni­ty

A service from the Financial Times